Get started
AstraZeneca PLC ADRAstraZeneca PLC ADRAstraZeneca PLC ADR

AstraZeneca PLC ADR

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

AZND chart


Full chart

Key facts today


AstraZeneca is assessed in a report on the potential effects of U.S. tariffs and drug pricing reforms, indicating that near-term risks from these initiatives are manageable for the company.
AstraZeneca has canceled plans to invest 450 million pounds in a new vaccine plant in northern England, attributing the decision to a reduction in government support.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪251.03 B‬ USD
Dividend yield (indicated)
1.90%
Price to earnings Ratio (TTM)
50.95
Basic EPS (TTM)
0.95 USD
Net income (FY)
‪6.25 B‬ USD
Revenue (FY)
‪48.03 B‬ USD
Shares float
—
Beta (1Y)
0.01

About AstraZeneca PLC


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Pascal Soriot
Website
astrazeneca.com
Headquarters
Cambridge
Founded
1913
ISIN
ARDEUT112489
FIGI
BBG000DDGBJ4
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZND.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AZND news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AZND highest yielding bonds


A
AZN5193317
AstraZeneca Finance LLC 1.75% 28-MAY-2028
Yield to maturity
—
Maturity date
May 28, 2028
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
—
Maturity date
Sep 18, 2042
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
—
Maturity date
May 28, 2031
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
—
Maturity date
Mar 3, 2033
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
—
Maturity date
Sep 15, 2037
A
AZN5549114
AstraZeneca Finance LLC 4.875% 03-MAR-2028
Yield to maturity
—
Maturity date
Mar 3, 2028
A
AZN5549115
AstraZeneca Finance LLC 4.9% 03-MAR-2030
Yield to maturity
—
Maturity date
Mar 3, 2030
US46353AX6
AstraZeneca PLC 2.125% 06-AUG-2050
Yield to maturity
—
Maturity date
Aug 6, 2050
A
US4636NAN3
AstraZeneca Finance LLC 5.0% 26-FEB-2034
Yield to maturity
—
Maturity date
Feb 26, 2034
US46353AL2
AstraZeneca PLC 3.375% 16-NOV-2025
Yield to maturity
—
Maturity date
Nov 16, 2025
A
US4636NAK9
AstraZeneca Finance LLC 4.8% 26-FEB-2027
Yield to maturity
—
Maturity date
Feb 26, 2027

See all AZND bonds 

Sparks


Curated watchlists where AZND is featured.

See all sparks